97 related articles for article (PubMed ID: 22914348)
1. Clinicopathologic features and prognosis of young patients with hepatocellular carcinoma in a large German cohort.
Niederle IM; Wörns MA; Koch S; Nguyen-Tat M; Düber C; Otto G; Schuchmann M; Galle PR; Weinmann A
J Clin Gastroenterol; 2012 Oct; 46(9):775-8. PubMed ID: 22914348
[TBL] [Abstract][Full Text] [Related]
2. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
3. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in patients without cirrhosis in Italy.
Giannini EG; Marenco S; Bruzzone L; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F
Dig Liver Dis; 2013 Feb; 45(2):164-9. PubMed ID: 23047000
[TBL] [Abstract][Full Text] [Related]
5. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients.
Trevisani F; D'Intino PE; Grazi GL; Caraceni P; Gasbarrini A; Colantoni A; Stefanini GF; Mazziotti A; Gozzetti G; Gasbarrini G; Bernardi M
Cancer; 1996 Jun; 77(11):2223-32. PubMed ID: 8635088
[TBL] [Abstract][Full Text] [Related]
9. Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening.
Lam CM; Chan AO; Ho P; Ng IO; Lo CM; Liu CL; Poon RT; Fan ST
Aliment Pharmacol Ther; 2004 Apr; 19(7):771-7. PubMed ID: 15043518
[TBL] [Abstract][Full Text] [Related]
10. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in the youth. A comparative analysis with hepatocellular carcinoma in adulthood.
Hernández-Castillo E; Mondragón-Sánchez R; Garduno-Lopez AL; Gómez-Gómez E; Ruiz-Molina JM; Oñate-Ocaña LF; Bernal-Maldonado R
Hepatogastroenterology; 2005; 52(63):903-7. PubMed ID: 15966229
[TBL] [Abstract][Full Text] [Related]
12. Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients.
Chen CH; Chang TT; Cheng KS; Su WW; Yang SS; Lin HH; Wu SS; Lee CM; Changchien CS; Chen CJ; Sheu JC; Chen DS; Lu SN
Liver Int; 2006 Sep; 26(7):766-73. PubMed ID: 16911457
[TBL] [Abstract][Full Text] [Related]
13. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
14. Fibrolamellar hepatic carcinoma in an area with a low incidence of primary liver cancer: a retrospective study.
Kaczynski J; Gustavsson B; Hansson G; Wallerstedt S
Eur J Surg; 1996 May; 162(5):367-71. PubMed ID: 8781917
[TBL] [Abstract][Full Text] [Related]
15. Hepatic resection for hepatocellular carcinoma in elderly patients.
Yeh CN; Lee WC; Jeng LB; Chen MF
Hepatogastroenterology; 2004; 51(55):219-23. PubMed ID: 15011868
[TBL] [Abstract][Full Text] [Related]
16. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?
Cho SJ; Yoon JH; Hwang SS; Lee HS
J Gastroenterol Hepatol; 2007 Aug; 22(8):1226-31. PubMed ID: 17498220
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
[TBL] [Abstract][Full Text] [Related]
18. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
[TBL] [Abstract][Full Text] [Related]
19. High incidence of hepatocellular carcinoma in ESRD patients: caused by high hepatitis rate or 'uremia'? a population-based study.
Hwang JC; Weng SF; Weng RH
Jpn J Clin Oncol; 2012 Sep; 42(9):780-6. PubMed ID: 22782961
[TBL] [Abstract][Full Text] [Related]
20. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
